{"type": "financial", "level": "hallu", "file": "2U, Inc..txt", "context_order": 0, "question": "What is the demographic breakdown of employees working in the Asia-Pacific region?", "prediction": "The 10-K does not provide a breakdown of employee demographics by region, only by broad categories (US, South Africa, and \"other jurisdictions\").  It states 414 employees are located in jurisdictions other than the US and South Africa, but does not specify how many of those are located in the Asia-Pacific region, nor their demographic breakdown.\n", "ground_truth": "The financial statement does not provide information on the demographic breakdown of employees working in the Asia-Pacific region."}
{"type": "financial", "level": "hallu", "file": "2U, Inc..txt", "context_order": 1, "question": "What are the company's specific strategies for expanding into the Asian market?", "prediction": "The 10-K doesn't detail specific strategies for any single Asian country, but mentions that edX has significant global (including non-U.S.) web traffic and learners. The company states its global expansion strategy relies on leveraging this existing edX presence to partner with top-tier international universities and offer programs to attract non-U.S. learners.  It also acknowledges the general challenges of international expansion such as localization and regulatory compliance.\n", "ground_truth": "The financial statement does not mention any specific strategies for expanding into the Asian market."}
{"type": "financial", "level": "hallu", "file": "2U, Inc..txt", "context_order": 2, "question": "What percentage of the university clients have opted for performance-based compensation agreements?", "prediction": "The 10-K doesn't specify the percentage of university clients with performance-based compensation agreements. It mentions performance-based vesting conditions for some employee PRSUs, but not for client contracts. It states that most degree programs compensate the company based on a fixed percentage of tuition revenue.\n", "ground_truth": "The financial statement does not provide information on the percentage of university clients that have opted for performance-based compensation agreements."}
{"type": "financial", "level": "hallu", "file": "2U, Inc..txt", "context_order": 3, "question": "What is the company's projected revenue for 2024?", "prediction": "The financial statement does not include projected revenue for 2024. It does mention that the number of newly launched programs is expected to increase significantly in 2024, but does not quantify the revenue impact.  It also notes the company expects further profitability improvements in 2024 due to the 2022 Strategic Realignment Plan and other performance improvement exercises.\n", "ground_truth": "The financial statement does not provide any projections or estimates for the company's revenue in 2024."}
{"type": "financial", "level": "hallu", "file": "2U, Inc..txt", "context_order": 4, "question": "What is the company's strategy for entering new geographic markets?", "prediction": "2U leverages edX's significant global web traffic and large non-US learner base to partner with top-tier international universities and attract non-US learners to their existing offerings.\n", "ground_truth": "The financial statement does not provide information on the company's strategy for entering new geographic markets."}
{"type": "financial", "level": "hallu", "file": "2U, Inc..txt", "context_order": 5, "question": "What are the projected interest expenses for 2024?", "prediction": "The filing does not provide the projected interest expense for 2024. It does state that a 100 basis point change in interest rates would have changed 2023 interest expense by about $4.2 million.  However, future interest rates, and thus interest expense, cannot be predicted with certainty.\n", "ground_truth": "The financial statement does not provide projections for interest expenses in 2024."}
{"type": "financial", "level": "hallu", "file": "2U, Inc..txt", "context_order": "full", "question": "What is 2U, Inc.'s strategy for entering emerging markets in the next five years?", "prediction": "The 10-K doesn't specify a 5-year plan for emerging markets. It mentions edX's global traffic and non-US learner base as opportunities for expansion with top-tier international universities and attracting more non-US learners to existing offerings.  Essentially, they intend to leverage the edX platform for international growth, but detailed specifics aren't provided.\n", "ground_truth": "The financial statement does not mention 2U, Inc.'s strategy for entering emerging markets in the next five years."}
{"type": "financial", "level": "hallu", "file": "3D Systems Corp..txt", "context_order": 0, "question": "What are the specific sustainability initiatives the company is focusing on for 2023?", "prediction": "The provided financial statement does not contain the company's specific sustainability initiatives for 2023. While it mentions sustainability is part of the Chief Risk & Compliance Officer's responsibilities and directs readers to the company website for further information, that detail is not included in this document. \n", "ground_truth": "The document does not provide specific details about the company's sustainability initiatives for 2023."}
{"type": "financial", "level": "hallu", "file": "3D Systems Corp..txt", "context_order": 1, "question": "What are the future trends expected in the additive manufacturing industry?", "prediction": "The additive manufacturing industry is expected to experience rapid technological change and development in hardware, software, and materials, with increasing demand for faster print speeds and enhanced material functionality.  Cloud-based software solutions and automation are expected to play an increasingly important role in managing digital manufacturing workflows.  The application of additive manufacturing in regenerative medicine, including bioprinting of organs and tissues, is also a key area for future growth.\n", "ground_truth": "The document does not provide any information on future trends expected in the additive manufacturing industry."}
{"type": "financial", "level": "hallu", "file": "3D Systems Corp..txt", "context_order": 2, "question": "What are the specific strategies for expansion in the Asia-Pacific region for the upcoming fiscal year?", "prediction": "The provided financial statement does not contain specific strategies for expansion in the Asia-Pacific region (APAC) for any upcoming fiscal year.  It only mentions current operations and marketing in the APAC region along with other regions.  Future plans are not detailed.\n", "ground_truth": "The financial statement does not mention any specific strategies for expansion in the Asia-Pacific region for the upcoming fiscal year."}
{"type": "financial", "level": "hallu", "file": "3D Systems Corp..txt", "context_order": 3, "question": "What is the projected growth rate for the company's industrial solutions segment over the next five years?", "prediction": "The provided financial statement does not include projected growth rates for the Industrial Solutions segment or any other segment. It only mentions that the company expects additional investments and growth opportunities.  For specific growth projections, you would need to consult other company publications like investor presentations or analyst reports. \n", "ground_truth": "The document does not provide any projected growth rate for the company's industrial solutions segment over the next five years."}
{"type": "financial", "level": "hallu", "file": "3D Systems Corp..txt", "context_order": 4, "question": "What is the company's dividend payout ratio for the year ended December 31, 2022?", "prediction": "0%.  The company states it does not currently pay dividends and has not paid any dividends on its common stock.\n", "ground_truth": "The document does not provide information on the company's dividend payout ratio for the year ended December 31, 2022."}
{"type": "financial", "level": "hallu", "file": "3D Systems Corp..txt", "context_order": 5, "question": "How does the company plan to allocate its research and development budget for the next fiscal year?", "prediction": "The provided financial statement does not specify how the R&D budget will be allocated in the next fiscal year. It only mentions ongoing R&D programs for new product development, product enhancement, and regenerative medicine applications.  No specific allocation amounts or percentages are given.\n", "ground_truth": "The document does not mention any specific plans for the allocation of the research and development budget for the next fiscal year."}
{"type": "financial", "level": "hallu", "file": "3D Systems Corp..txt", "context_order": "full", "question": "What is the expected completion date for the Oqton software integration into the Oqton Manufacturing Operating System?", "prediction": "The 10-K doesn't provide a specific completion date for the software integration. It mentions ongoing efforts to integrate 3D Systems' legacy software (Geomagic, 3D Sprint, 3DXpert) into the Oqton MOS.\n", "ground_truth": "The financial report does not provide a specific expected completion date for the Oqton software integration into the Oqton Manufacturing Operating System."}
{"type": "financial", "level": "hallu", "file": "Block, Inc..txt", "context_order": 0, "question": "What were the results of the company's environmental sustainability initiatives?", "prediction": "The report mentions an environmental sustainability goal of net zero carbon for operations by 2030, but doesn't provide specific results on progress toward that goal.  More information may be available in their annual Corporate Social Responsibility Report.\n", "ground_truth": "The financial statement does not mention or provide any details about the results of the company's environmental sustainability initiatives."}
{"type": "financial", "level": "hallu", "file": "Block, Inc..txt", "context_order": 1, "question": "What is the expected timeline for the integration of Afterpay with the company's systems?", "prediction": "The document does not provide a specific timeline for the full integration of Afterpay, only mentioning that it needs to be completed \"in a timely and effective manner\". It acknowledges ongoing challenges in the integration process.\n", "ground_truth": "The financial statement does not specify an expected timeline for the integration of Afterpay with the company's systems."}
{"type": "financial", "level": "hallu", "file": "Block, Inc..txt", "context_order": 2, "question": "What specific strategies are in place for integrating new acquisitions into the current business model?", "prediction": "The document does not detail specific acquisition integration strategies beyond mentioning the importance of integrating technology, IT systems, personnel, and corporate infrastructures, while maintaining focus on product and service quality. It also acknowledges challenges like conforming standards and controls, coordinating geographically dispersed organizations, and potential unknown liabilities.  Specific integration strategies for each acquisition are not described.\n", "ground_truth": "The financial statement does not provide details about specific strategies for integrating new acquisitions into the business model."}
{"type": "financial", "level": "hallu", "file": "Block, Inc..txt", "context_order": 3, "question": "What strategies has the company implemented to reduce the impact of Bitcoin price volatility on its profits?", "prediction": "Block recognizes revenue from Bitcoin sales on a gross basis (the total sale amount), while recognizing the cost of the Bitcoin at the time of sale.  This approach, while creating large Bitcoin revenue numbers, results in low gross profit margins (around 3%) on Bitcoin sales, thereby minimizing the effect of price volatility on overall profitability.\n", "ground_truth": "The financial statement does not detail any specific strategies the company has implemented to reduce the impact of Bitcoin price volatility on its profits."}
{"type": "financial", "level": "hallu", "file": "Block, Inc..txt", "context_order": 4, "question": "How does the company plan to diversify its hardware product offerings in 2024?", "prediction": "The 10-K doesn't describe plans to diversify hardware product offerings in 2024. It mentions existing hardware like readers, Square Stand, Register, and Terminal, and discusses supply chain risks and integration with operating systems, but not diversification strategies for hardware in the coming year.  Instead, it focuses on  maintaining a flexible platform, AI, and expanding banking services as key priorities for Square.\n", "ground_truth": "The financial statement does not provide specifics on plans to diversify hardware product offerings in 2024."}
{"type": "financial", "level": "hallu", "file": "Block, Inc..txt", "context_order": 5, "question": "What is the company's strategy for expanding its bitcoin holdings in the next fiscal year?", "prediction": "The provided financial statement does not disclose the company's strategy for expanding its bitcoin holdings in the next fiscal year. While it mentions the company believes in bitcoin as an instrument of economic empowerment and intends to hold its current investments long-term, it also states it will reassess its bitcoin investment relative to its balance sheet.  No specific plans for future purchases are mentioned.\n", "ground_truth": "The document does not provide any information regarding the company's strategy for expanding its bitcoin holdings in the next fiscal year."}
{"type": "financial", "level": "hallu", "file": "Block, Inc..txt", "context_order": "full", "question": "What strategies are implemented to increase customer acquisition within the TIDAL ecosystem?", "prediction": "TIDAL leverages unique content, experiences, and features to attract artists and fans.  It offers a large music and video catalog and fosters closer artist-fan relationships.  TIDAL also provides artists with entrepreneurial tools.\n", "ground_truth": "The document does not provide information regarding specific strategies implemented to increase customer acquisition within the TIDAL ecosystem."}
{"type": "financial", "level": "hallu", "file": "C.H. ROBINSON WORLDWIDE, INC..txt", "context_order": 0, "question": "What are the specific future growth strategies for the Australian market?", "prediction": "The provided financial statement does not include specific growth strategies for individual markets like Australia. It mentions global expansion in key industries, trade lanes, and geographies and digitization of tools to support organic growth, but no details about particular regional approaches.\n", "ground_truth": "The document does not specify any future growth strategies for the Australian market."}
{"type": "financial", "level": "hallu", "file": "C.H. ROBINSON WORLDWIDE, INC..txt", "context_order": 1, "question": "What is the company's policy regarding remote work for its employees?", "prediction": "While the document mentions \"flexible work arrangements\" and optimizing real estate footprint in consideration of these arrangements, it does *not* specifically detail a remote work policy.\n", "ground_truth": "The financial statement does not mention the company's policy regarding remote work for its employees."}
{"type": "financial", "level": "hallu", "file": "C.H. ROBINSON WORLDWIDE, INC..txt", "context_order": 2, "question": "How many new customers did C.H. Robinson acquire in 2023?", "prediction": "The text doesn't state exactly how many *new* customers were acquired in 2023, only that they served *more than 90,000 customers worldwide* during that year and that they've grown *by adding new customers and by increasing...volumes with existing customers*.  Therefore, it's impossible to determine the number of new customers acquired solely from this report.\n", "ground_truth": "The financial statement does not provide information on the number of new customers acquired by C.H. Robinson in 2023."}
{"type": "financial", "level": "hallu", "file": "C.H. ROBINSON WORLDWIDE, INC..txt", "context_order": 3, "question": "What were the primary drivers for the change in operating cash flows between 2021 and 2023?", "prediction": "The primary drivers were increased net income and sequential declines in net operating working capital in 2022 (resulting in significantly higher operating cash flow that year), followed by a decline in net income in 2023 due to weak freight demand and excess carrier capacity.\n", "ground_truth": "The financial statement does not provide specific details on the primary drivers for the change in operating cash flows between 2021 and 2023."}
{"type": "financial", "level": "hallu", "file": "C.H. ROBINSON WORLDWIDE, INC..txt", "context_order": 4, "question": "What are the environmental sustainability initiatives undertaken by the company?", "prediction": "C.H. Robinson focuses on reducing its own greenhouse gas emissions (achieved a 47% reduction in Scope 1 and 2 carbon intensity by 2023, exceeding its 40% by 2025 goal), helping customers achieve their sustainability targets (using tools like Emissions IQ™ and supply chain optimization), and advancing industry sustainability through collaborations and research sponsorships.  Robinson Fresh also focuses on reducing food waste and using sustainable packaging.\n", "ground_truth": "The financial statement does not mention any specific environmental sustainability initiatives undertaken by the company."}
{"type": "financial", "level": "hallu", "file": "C.H. ROBINSON WORLDWIDE, INC..txt", "context_order": 5, "question": "What are the details regarding the company's latest innovation in logistics technology?", "prediction": "C.H. Robinson launched several new technology tools, including Procure IQ® for optimal transportation purchasing, Emissions IQ® for carbon emissions visibility and reduction, and Market Rate IQ™ to identify spot freight patterns for increased savings.  They also continue to develop their Navisphere® platform, adding features like Navisphere Vision™ for global freight visibility, Navisphere Insight™ for data-driven insights, and Navisphere Optimizer™ for route and carrier optimization.\n", "ground_truth": "The document does not provide any details regarding the company's latest innovation in logistics technology."}
{"type": "financial", "level": "hallu", "file": "C.H. ROBINSON WORLDWIDE, INC..txt", "context_order": "full", "question": "What strategies does C.H. Robinson plan to implement to expand its presence in South America beyond its current operations?", "prediction": "The provided financial statement details C.H. Robinson's *divestiture* of its operations in Argentina (due to economic and political instability) and transition to using a local independent agent.  It does *not* describe any strategies for expanding its South American presence beyond that change.\n", "ground_truth": "The financial statement does not mention any specific strategies C.H. Robinson plans to implement to expand its presence in South America beyond its current operations."}
{"type": "financial", "level": "hallu", "file": "EXACT SCIENCES CORPORATION.txt", "context_order": 0, "question": "What were the specific research and development costs related to the MRD test in 2023?", "prediction": "The document does not break down the specific R&D costs solely dedicated to the Oncodetect MRD test. It mentions increased MRD (and MCED) research activity in 2023, offsetting a decrease in BLUE-C trial costs. However, the total R&D expense for 2023 was $425.9 million, encompassing personnel, direct research, facilities, stock compensation, professional fees, and other expenses.  No further breakdown of costs within each category is provided. \n", "ground_truth": "The financial statement does not disclose specific research and development costs related to the MRD test for the year 2023."}
{"type": "financial", "level": "hallu", "file": "EXACT SCIENCES CORPORATION.txt", "context_order": 1, "question": "What is the company's strategy for entering the African market?", "prediction": "The provided financial statement does not mention any specific strategy for entering the African market. While it discusses international expansion and mentions exploring opportunities in markets outside the US, it does not specifically address Africa.\n", "ground_truth": "The financial statement does not mention any strategy for entering the African market."}
{"type": "financial", "level": "hallu", "file": "EXACT SCIENCES CORPORATION.txt", "context_order": 2, "question": "What is the projected cash flow from operations for the next fiscal year?", "prediction": "The statement says that cash and marketable securities on hand, combined with cash flow from operations, are expected to be sufficient to fund operations for the next twelve months, but it does not provide a specific projection for cash flow from operations for the next fiscal year.", "ground_truth": "The financial statement does not provide information about the projected cash flow from operations for the next fiscal year."}
{"type": "financial", "level": "hallu", "file": "EXACT SCIENCES CORPORATION.txt", "context_order": 3, "question": "What is the company's plan for diversifying its product portfolio in 2024?", "prediction": "Exact Sciences plans to advance new tests in colorectal cancer screening, molecular residual disease (MRD), and multi-cancer early detection (MCED).  They will focus on obtaining FDA approval and securing coverage for their next generation Cologuard test.\n", "ground_truth": "The financial statement does not mention any specific plans for diversifying the company's product portfolio in 2024."}
{"type": "financial", "level": "hallu", "file": "EXACT SCIENCES CORPORATION.txt", "context_order": 4, "question": "What are the company's projected capital expenditures for the next fiscal year?", "prediction": "$150.0 million\n", "ground_truth": "The financial statement does not provide any information on the company's projected capital expenditures for the next fiscal year."}
{"type": "financial", "level": "hallu", "file": "EXACT SCIENCES CORPORATION.txt", "context_order": 5, "question": "What is the projected impact of inflation on the company's leasing expenses?", "prediction": "The filing does not quantify the projected impact of inflation on leasing expenses. It mentions inflation as a general risk factor affecting profitability and acknowledges that operating costs, such as labor and supplies, are subject to inflation, but it does not specifically project how inflation will impact future leasing expenses. \n", "ground_truth": "The financial statement does not provide any information on the projected impact of inflation on the company's leasing expenses."}
{"type": "financial", "level": "hallu", "file": "EXACT SCIENCES CORPORATION.txt", "context_order": "full", "question": "What is the projected market share growth for the next-generation Cologuard test?", "prediction": "The provided financial statement does not contain projections for market share growth of the next-generation Cologuard test. It mentions the test's FDA submission and anticipated launch but not specific market share projections.\n", "ground_truth": "The financial statement does not provide information regarding the projected market share growth for the next-generation Cologuard test."}
{"type": "financial", "level": "hallu", "file": "Esperion Therapeutics Inc.txt", "context_order": 0, "question": "What was the average salary of the employees in the company during the fiscal year?", "prediction": "The financial statement does not provide the average salary of employees. It discloses the number of full-time employees as of December 31, 2023 (240) and some information about employee education levels and stock awards.  However, details on total salary expenses or average salary are not included.\n", "ground_truth": "The financial statement does not provide information on the average salary of the employees in the company during the fiscal year."}
{"type": "financial", "level": "hallu", "file": "Esperion Therapeutics Inc.txt", "context_order": 1, "question": "What are the specific budget allocations for employee training and development programs?", "prediction": "The provided financial statement does not contain specific budget allocations for employee training and development programs. It mentions these programs exist to attract and retain talent but doesn't break down the associated costs.\n", "ground_truth": "The financial statement does not provide specific budget allocations for employee training and development programs."}
{"type": "financial", "level": "hallu", "file": "Esperion Therapeutics Inc.txt", "context_order": 2, "question": "What are the preferred interest rates on loans provided by third-party payors?", "prediction": "This financial statement does not provide information on loan interest rates from third-party payors. It focuses on Esperion Therapeutics' financial performance and doesn't detail their payors' lending practices.\n", "ground_truth": "The financial statement does not mention preferred interest rates on loans provided by third-party payors."}
{"type": "financial", "level": "hallu", "file": "Esperion Therapeutics Inc.txt", "context_order": 3, "question": "What are the projected R&D expenses for the next fiscal year?", "prediction": "R&D expenses are expected to decrease substantially in 2024, after having completed the CLEAR Outcomes CVOT and submitted regulatory filings in 2023.  Some R&D expenses will continue for pursuing other development programs and additional indications.\n", "ground_truth": "The financial statement does not provide any projected R&D expenses for the next fiscal year."}
{"type": "financial", "level": "hallu", "file": "Esperion Therapeutics Inc.txt", "context_order": 4, "question": "What is the growth rate of the employees' salaries in 2024?", "prediction": "The provided financial statement does not include information on projected salary growth rates for 2024. It mentions an expected increase in selling, general, and administrative expenses due to increased headcount, but not the specific breakdown of those expenses.\n", "ground_truth": "The financial statement does not mention or provide information on the growth rate of employees' salaries in 2024."}
{"type": "financial", "level": "hallu", "file": "Esperion Therapeutics Inc.txt", "context_order": 5, "question": "What are the company's strategies for entering new international markets?", "prediction": "Esperion plans to enter new markets outside the US, Europe, Japan, and the existing Daiichi Sankyo territories by forming additional collaborations with pharmaceutical companies.  They will consider factors like applicable indications, development costs, and available resources when choosing partners.\n", "ground_truth": "The document does not mention any strategies for entering new international markets."}
{"type": "financial", "level": "hallu", "file": "Esperion Therapeutics Inc.txt", "context_order": "full", "question": "How many patents does the company hold in Asia for its LDL-C lowering therapies?", "prediction": "The document states the company has over 25 issued patents and over 80 pending patent applications outside the US, but it doesn't specify how many are in Asia, nor does it separate out LDL-C lowering therapies from other therapies.  It does detail specific US and European patents related to the LDL-C lowering therapy.\n", "ground_truth": "The document does not provide information on the number of patents held by the company in Asia for its LDL-C lowering therapies."}
{"type": "financial", "level": "hallu", "file": "MediaAlpha, Inc..txt", "context_order": 0, "question": "What strategies are in place for managing climate change risks?", "prediction": "The provided financial statement does not contain any information about climate change risks or strategies for managing them.  It focuses on financial performance, operations, and regulatory compliance within the insurance customer acquisition market.\n", "ground_truth": "The financial statement does not mention any strategies for managing climate change risks."}
{"type": "financial", "level": "hallu", "file": "MediaAlpha, Inc..txt", "context_order": 1, "question": "What percentage of revenue comes from the education vertical market?", "prediction": "MediaAlpha does not operate in the education vertical market.  Their revenue comes primarily from property & casualty insurance (42.3%), health insurance (48%), life insurance (6.3%), and other (3.4%) for the year ended December 31, 2023.\n", "ground_truth": "The document does not provide specific information on the percentage of revenue that comes from the education vertical market."}
{"type": "financial", "level": "hallu", "file": "MediaAlpha, Inc..txt", "context_order": 2, "question": "What are the main strategies the company plans to implement to address potential supply chain disruptions?", "prediction": "The document does not specifically address supply chain disruptions as they relate to the company's *own* operations or ability to deliver its services. However, it acknowledges that supply chain constraints and cost increases experienced by the auto insurance industry beginning in 2021 have negatively impacted P&C carrier profitability, leading to reduced customer acquisition spending on MediaAlpha's platform.  The company anticipates increased spending as carrier profitability recovers.  No specific strategies to address these *external* disruptions are outlined, as they are largely outside the company's direct control.\n", "ground_truth": "The document does not specify any main strategies the company plans to implement to address potential supply chain disruptions."}
{"type": "financial", "level": "hallu", "file": "MediaAlpha, Inc..txt", "context_order": 3, "question": "What is the company's current cash burn rate?", "prediction": "The provided financial statement does not explicitly state a cash burn rate. However, it does reveal a net loss of $56.6 million for the year ended December 31, 2023, and $20.2 million net cash provided by operating activities during the same period.  More information is needed to compute an accurate burn rate.\n", "ground_truth": "The financial statement does not specify the company's current cash burn rate."}
{"type": "financial", "level": "hallu", "file": "MediaAlpha, Inc..txt", "context_order": 4, "question": "What was the company's employee turnover rate for the year 2023?", "prediction": "The document does not explicitly state the employee turnover rate. It mentions low turnover but doesn't provide a specific percentage or number.  It does say that average employee headcount was 142 in 2023 and 137 at year end.\n", "ground_truth": "The financial statement does not provide information about the company's employee turnover rate for the year 2023."}
{"type": "financial", "level": "hallu", "file": "MediaAlpha, Inc..txt", "context_order": 5, "question": "What strategies has the company implemented to expand its market presence internationally?", "prediction": "The provided financial statement does not contain information about international expansion strategies. It primarily focuses on the U.S. market and mentions international presence only in the context of employee location (Taipei) and general legal compliance.  There is no discussion of specific plans or activities aimed at growing the business internationally.\n", "ground_truth": "The financial statement does not provide information on any strategies that the company has implemented to expand its market presence internationally."}
{"type": "financial", "level": "hallu", "file": "MediaAlpha, Inc..txt", "context_order": "full", "question": "What are the company’s plans regarding expansion into international markets?", "prediction": "While MediaAlpha's primary focus is growing its core insurance verticals in the United States, its platform is vertical-agnostic.  This means it *could* expand into international markets or other sectors (like consumer finance or education) if deemed opportune, but there are no stated plans to do so currently.\n", "ground_truth": "The document does not provide information on the company's plans regarding expansion into international markets."}
{"type": "financial", "level": "hallu", "file": "Mind Medicine (MindMed) Inc..txt", "context_order": 0, "question": "What are the projected environmental impacts of the company's production facilities for the next five years?", "prediction": "The provided financial statement does not include projections of environmental impacts from the company's production. It states that the company does not own or operate any manufacturing facilities and relies on third-party CDMOs for production.  Therefore, assessing the environmental impact would require further information about those specific CDMOs and their practices.\n", "ground_truth": "The document does not provide any information on the projected environmental impacts of the company's production facilities for the next five years."}
{"type": "financial", "level": "hallu", "file": "Mind Medicine (MindMed) Inc..txt", "context_order": 1, "question": "What are the projected sales figures for the new drug in its first year on the market?", "prediction": "This financial statement does not include sales projections. It states that the company has not generated any revenue to date and does not anticipate generating any revenue from product sales for the next several years, if ever.\n", "ground_truth": "The document does not provide any projected sales figures for the new drug in its first year on the market."}
{"type": "financial", "level": "hallu", "file": "Mind Medicine (MindMed) Inc..txt", "context_order": 2, "question": "What are the specific financial metrics used to evaluate the success of the digital medicine programs?", "prediction": "The statement doesn't specify financial metrics for evaluating digital medicine program success. It only mentions that the programs' timelines and investments depend on the related drug program's progression.\n", "ground_truth": "The document does not provide specific financial metrics used to evaluate the success of the digital medicine programs."}
{"type": "financial", "level": "hallu", "file": "Mind Medicine (MindMed) Inc..txt", "context_order": 3, "question": "What are the projected market growth rates for MM120 and MM402 after commercial approval?", "prediction": "This 10-K does not contain projections of market growth rates for MM120 or MM402.  It does mention that generalized anxiety disorder (GAD), a target indication for MM120, affects about 10% of US adults in their lifetime. It also states estimates for autism spectrum disorder (ASD), for which MM402 is being developed, vary between 1/40 and 1/500.\n", "ground_truth": "The financial statement does not provide any projected market growth rates for MM120 and MM402 after potential commercial approval."}
{"type": "financial", "level": "hallu", "file": "Mind Medicine (MindMed) Inc..txt", "context_order": 4, "question": "What is the projected timeline for the launch of MM120 and MM402 in the Asian market?", "prediction": "This 10-K does not mention timelines for MM120 or MM402 related to the Asian market.  It states the company will *evaluate* market potential and regulatory pathways in the EU, UK, and regions outside the US.\n", "ground_truth": "The financial statement does not provide any specific information regarding the projected timeline for the launch of MM120 and MM402 in the Asian market."}
{"type": "financial", "level": "hallu", "file": "Mind Medicine (MindMed) Inc..txt", "context_order": 5, "question": "What is the company's strategy for entering the Asian market?", "prediction": "The provided text doesn't mention a specific strategy for entering the Asian market. It states the company will *evaluate* market potential and regulatory pathways in countries and regions outside the US, including the EU and UK, to determine the best opportunities for their product candidates.\n", "ground_truth": "The financial statement does not mention any specific strategy for entering the Asian market."}
{"type": "financial", "level": "hallu", "file": "Mind Medicine (MindMed) Inc..txt", "context_order": "full", "question": "What is the price range for the company's proposed digital health tools?", "prediction": "The provided text does not include pricing information for the company's proposed digital health tools. It only mentions that digital medicine projects are under development to complement drug development programs, and that these projects' timelines and investments are contingent on the related drug program's progression. \n", "ground_truth": "The financial statement does not mention any price range for the company's proposed digital health tools."}
{"type": "financial", "level": "hallu", "file": "NVIDIA Corporation.txt", "context_order": 0, "question": "What strategies does NVIDIA have for acquiring new businesses or technologies?", "prediction": "NVIDIA's acquisition and investment strategy focuses on businesses with products, services, and technologies that can expand or enhance their existing strategic objectives, particularly in accelerated computing, AI, computer graphics, and autonomous vehicles.  They may acquire companies directly or make strategic investments, including in private and public companies, to support key business initiatives and further these objectives.\n", "ground_truth": "The document does not provide specific information on NVIDIA's strategies for acquiring new businesses or technologies."}
{"type": "financial", "level": "hallu", "file": "NVIDIA Corporation.txt", "context_order": 1, "question": "What is the company's profit margin in the new generative AI services sector?", "prediction": "The document does not break out a profit margin specifically for generative AI services. While it mentions generative AI as a driver of demand and mentions specific generative AI products (like NVIDIA AI Foundations and NeMo), the financials are aggregated at the segment level (Compute & Networking, Graphics).  Therefore, a distinct generative AI profit margin cannot be determined from this report.\n", "ground_truth": "The document does not provide specific information on the company's profit margin in the new generative AI services sector."}
{"type": "financial", "level": "hallu", "file": "NVIDIA Corporation.txt", "context_order": 2, "question": "What are the specific interest rates applied to company's outstanding debt?", "prediction": "* **0.584%** Notes Due 2024\n* **3.20%** Notes Due 2026\n* **1.55%** Notes Due 2028\n* **2.85%** Notes Due 2030\n* **2.00%** Notes Due 2031\n* **3.50%** Notes Due 2040\n* **3.50%** Notes Due 2050\n* **3.70%** Notes Due 2060\n", "ground_truth": "The financial statement does not provide information on the specific interest rates applied to the company's outstanding debt."}
{"type": "financial", "level": "hallu", "file": "NVIDIA Corporation.txt", "context_order": 3, "question": "What are the company's plans for expansion in international markets in the next fiscal year?", "prediction": "The document doesn't specify expansion plans for *specific* international markets in fiscal year 2025. It mentions working to expand the Data Center product portfolio to offer solutions not subject to US licensing requirements (targeting China and other restricted markets), but broader international expansion strategies are not detailed.\n", "ground_truth": "The financial statement does not detail specific plans for expansion in international markets for the next fiscal year."}
{"type": "financial", "level": "hallu", "file": "NVIDIA Corporation.txt", "context_order": 4, "question": "What specific technology developments did NVIDIA invest in during the fiscal year 2024?", "prediction": "In FY2024, NVIDIA launched AI inference platforms optimized for generative AI and LLMs, introduced NVIDIA DGX Cloud and AI Foundations for custom large language models, announced NVIDIA Spectrum-X networking platform, released GeForce RTX 4060/4070 GPUs,  NVIDIA Avatar Cloud Engine for Games and DLSS 3.5,  announced NVIDIA Omniverse Cloud, and partnered with MediaTek to develop automotive chips with NVIDIA GPU chiplet IP. They also started shipping Grace CPU and Grace Hopper Superchips.\n", "ground_truth": "The financial statements do not list specific technology developments that NVIDIA invested in during the fiscal year 2024."}
{"type": "financial", "level": "hallu", "file": "NVIDIA Corporation.txt", "context_order": 5, "question": "What are the sustainability initiatives undertaken by the company in fiscal year 2024?", "prediction": "NVIDIA aims to match 100% of its global electricity use with renewable energy by the end of fiscal year 2025 and engage its manufacturing suppliers to adopt science-based emissions targets by fiscal year 2026. They are also developing Earth-2, a digital twin of Earth, to model climate change and explore mitigation strategies.  No material financial impact has been reported from these initiatives.\n", "ground_truth": "The document does not provide information on any sustainability initiatives undertaken by the company in fiscal year 2024."}
{"type": "financial", "level": "hallu", "file": "NVIDIA Corporation.txt", "context_order": "full", "question": "What is the projected growth rate for NVIDIA's AI solutions over the next five years?", "prediction": "The provided financial statement doesn't contain a specific projected growth rate for NVIDIA's AI solutions over the next five years. While it mentions strong demand and growth driven by AI applications, it doesn't quantify future growth projections.  Future growth in AI-related revenue depends on many factors, including demand for the NVIDIA Hopper GPU computing platform for large language models and other factors.\n", "ground_truth": "The document does not provide any specific projected growth rate for NVIDIA's AI solutions over the next five years."}
{"type": "financial", "level": "hallu", "file": "Paratek Pharmaceuticals Inc.txt", "context_order": 0, "question": "What are the future expansion plans for Paratek Pharmaceuticals in the African market?", "prediction": "The provided financial statement does not mention any specific expansion plans for Paratek Pharmaceuticals in the African market. It mentions plans to expand to select markets such as Japan, South Korea, and Europe, focusing on the rare disease indication of NTM, and also pursuing global expansion through collaborations or distribution.\n", "ground_truth": "The financial document does not provide information regarding the future expansion plans of Paratek Pharmaceuticals in the African market."}
{"type": "financial", "level": "hallu", "file": "Paratek Pharmaceuticals Inc.txt", "context_order": 1, "question": "What is the company's strategy for expanding into emerging markets?", "prediction": "The company plans to expand into select emerging markets like Japan, South Korea, and Europe through collaborations or distribution arrangements, focusing on the rare disease indication of NTM (non-tuberculous mycobacteria).\n", "ground_truth": "The financial statement does not mention the company's strategy for expanding into emerging markets."}
{"type": "financial", "level": "hallu", "file": "Paratek Pharmaceuticals Inc.txt", "context_order": 2, "question": "What is the long-term strategy for SEYSARA's expansion into European markets?", "prediction": "The company plans to expand SEYSARA to markets outside the U.S. and greater China region (where it is licensed to Almirall) through collaborations or distribution arrangements, leveraging a license from Almirall for necessary technology.\n", "ground_truth": "The document does not provide details on a long-term strategy for SEYSARA's expansion into European markets."}
{"type": "financial", "level": "hallu", "file": "Paratek Pharmaceuticals Inc.txt", "context_order": 3, "question": "How many employees does the company have?", "prediction": "As of February 28, 2023, Paratek Pharmaceuticals had 269 employees (268 full-time).\n", "ground_truth": "The document does not provide any information regarding the number of employees the company has."}
{"type": "financial", "level": "hallu", "file": "Paratek Pharmaceuticals Inc.txt", "context_order": 4, "question": "What is the company's strategy for expanding into Asian markets for its non-antibiotic products?", "prediction": "The provided financial statement does not include the company's strategy for expanding its non-antibiotic products into Asian markets. It focuses on antibiotics NUZYRA and SEYSARA, and discusses licensing agreements with Zai Lab for the Asian market.  No other product types or specific expansion plans for them are mentioned.\n", "ground_truth": "The financial statement does not provide any information on the company's strategy for expanding into Asian markets for its non-antibiotic products."}
{"type": "financial", "level": "hallu", "file": "Paratek Pharmaceuticals Inc.txt", "context_order": 5, "question": "What is the company's strategy for expanding into emerging markets?", "prediction": "The company plans to expand into select emerging markets like Japan, South Korea, and Europe through collaborations or distribution arrangements, focusing on the rare disease indication of NTM (non-tuberculous mycobacteria).\n", "ground_truth": "The financial statement does not discuss any strategies for expanding into emerging markets."}
{"type": "financial", "level": "hallu", "file": "Paratek Pharmaceuticals Inc.txt", "context_order": "full", "question": "What is the specific tax impact of international operations on the company's financials?", "prediction": "The primary international tax impact relates to withholding taxes on milestone payments received from the Zai Lab collaboration in China.  There's also a potential impact on the utilization of net operating loss (NOL) carryforwards, although the specifics aren't detailed in this document.\n", "ground_truth": "The financial statement does not provide information about the specific tax impact of international operations on the company's financials."}
{"type": "financial", "level": "hallu", "file": "Tesla, Inc..txt", "context_order": 0, "question": "How many patents did Tesla file in the year 2023?", "prediction": "The provided financial statement does not contain the number of patents Tesla filed in 2023. It mentions that Tesla seeks to protect its intellectual property through patents, but no specific numbers are given.", "ground_truth": "The document does not provide information on the number of patents Tesla filed in the year 2023."}
{"type": "financial", "level": "hallu", "file": "Tesla, Inc..txt", "context_order": 1, "question": "What is the projected growth rate for Tesla's solar energy systems installations in 2024?", "prediction": "The provided financial statement does not include the projected growth rate for Tesla's solar energy systems installations in 2024. It mentions a focus on ramping energy storage production and improving Solar Roof installation, but no specific growth figures are given.\n", "ground_truth": "The financial statement does not mention the projected growth rate for Tesla's solar energy systems installations in 2024."}
{"type": "financial", "level": "hallu", "file": "Tesla, Inc..txt", "context_order": 2, "question": "What sustainable energy initiatives is the company planning to implement in 2024?", "prediction": "The document outlines several ongoing initiatives rather than specific new plans for 2024.  These include: increasing electric vehicle production and affordability, developing next-generation battery and vehicle technology, expanding the Supercharger network (including NACS support), improving Solar Roof installation, and growing the energy storage business (especially Megapack). They will also be continuing R&D in AI, software, and robotics.\n", "ground_truth": "The financial statement does not mention any specific sustainable energy initiatives planned for implementation in 2024."}
{"type": "financial", "level": "hallu", "file": "Tesla, Inc..txt", "context_order": 3, "question": "What are the competitive strategies Tesla has implemented to enhance its market positioning?", "prediction": "Tesla emphasizes performance, attractive styling, and safety. It aims for lower cost of ownership through reduced manufacturing costs and tailored financial services.  It leverages its direct sales model, over-the-air software updates, in-app upgrades, and Supercharger network for competitive advantage, along with its focus on in-house design, engineering, and manufacturing, particularly of batteries and powertrains.  Additionally, Tesla is developing full self-driving technology and expanding into new vehicle segments like pickup trucks and commercial vehicles.\n", "ground_truth": "The financial statement does not provide information on specific competitive strategies Tesla has implemented to enhance its market positioning."}
{"type": "financial", "level": "hallu", "file": "Tesla, Inc..txt", "context_order": 4, "question": "What are the projected costs for expanding the automation facilities within the next five years?", "prediction": "The provided financial statement does not contain specific details on projected costs for expanding automation facilities within the next five years. It mentions capital expenditures exceeding $10 billion in 2024 and $8-10 billion in each of the following two years, which will support various projects including factory expansions and new technologies, but it doesn't break down automation spending specifically.\n", "ground_truth": "The financial statement does not provide information regarding the projected costs for expanding the automation facilities within the next five years."}
{"type": "financial", "level": "hallu", "file": "Tesla, Inc..txt", "context_order": 5, "question": "What is the projected revenue growth rate for Tesla's energy generation and storage segment over the next five years?", "prediction": "The provided financial statement does not offer specific projected growth rates for the energy generation and storage segment over the next five years. It mentions growth initiatives and increased revenue in 2023, but no concrete future projections are given.\n", "ground_truth": "The document does not provide information on the projected revenue growth rate for Tesla's energy generation and storage segment over the next five years."}
{"type": "financial", "level": "hallu", "file": "Tesla, Inc..txt", "context_order": "full", "question": "How much of Tesla's revenue in 2023 was derived from partnerships with other automotive manufacturers?", "prediction": "$1.79 billion from the sale of automotive regulatory credits.\n", "ground_truth": "The document does not specify how much of Tesla's revenue in 2023 was derived from partnerships with other automotive manufacturers."}
